4.2.2 Antipsychotic depot injections

Flupentixol decanoate
  • Depixol® injection 20mg/ml (£2.54 = 2ml ampoule)
  • Depixol® injection 100mg/ml ("Concentrate") (£6.25 = 1ml ampoule)
  • Depixol® injection 200mg/ml ("Low-volume") (£9.76 = 1ml ampoule)

Indications

Fluphenazine decanoate
  • Modecate® injection 25mg/ml (£2.26 = 1ml ampoule)
  • Modecate® injection 100mg/ml ("Concentrate") (£8.75 = 1ml ampoule)

Indications

Haloperidol
  • Haldol® haolperidol deconate injection 50mg in 1ml (£3.81 = 1ml ampoule)
  • Haldol® haloperidol deconate injection 100mg in 1ml (£5.05 = 1ml ampoule)

Indications

Zuclopenthixol decanoate
  • Injection 200mg in 1ml (£3.15 = 1ml ampoule)
  • Injection 500mg in 1ml ("Concentrate") (£3.72 = 1ml ampoule)

Indications

Aripiprazole
  • Abilify Maintena® prolonged release injection 400mg

Indications

Notes

  1. NICE TA213 Schizophrenia - aripiprazole (January 2011)
  2. NICE TA292 Bipolar disorder (adolescents) - aripiprazole (July 2013)
Olanzapine embonate
  • Zypadhera® prolonged release injection 210mg, 300mg, 405mg

Indications

Notes

  1. Olanzapine long-acting injection is associated with post-injection syndrome. Olanzapine should only be given in health-care facilities where administration of the injection and observation of patients post-injection can be undertaken safely and for at least three hours. The three-hour observation period should be extended as clinically appropriate for patients who exhibit any signs or symptoms consistent with olanzapine overdose. Olanzapine should only be administered by healthcare professionals trained in the appropriate injection technique. Training materials are available at: https://www.zypadhera.co.uk/SignIn.aspx
Paliperidone palmitate
  • Xeplion® prolonged release injection available as prefilled syringe: 50mg, 75mg, 100mg, 150mg
  • Trevicta® 3 monthly prolonged release injection available as prefilled syringe: 175mg, 263mg, 350mg, 525mg

Indications

Notes

  1. Please prescribe by brand to avoid confusion

 

Home > Formulary > Chapters > 4. Central Nervous System > 4.2 Drugs used in psychoses and related disorders > 4.2.2 Antipsychotic depot injections

 

  • First line
  • Second line
  • Specialist
  • Hospital